end-stage renal disease
Conditions
Interventions
Prevalent conventional hemodialysis patients will undergo a conventional
hemodialysis session to study the baseline kinetics and hemodynamics and will
subsequently undergo, in a random way, a 4-hour
Sponsors
Medisch Universitair Ziekenhuis Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: -prevalent stable CHD patients with insignificant residual urine production -AV-fistula enabling double-needle vascular access with blood flow rate of at least 350 ml/min -informed consent -age more than 18 years
Exclusion criteria
Exclusion criteria: -withdrawal of consent -acute intercurrent illness (infection, malignancy, cardiovascular event, uncontrolled diabetes)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is the removal of (especially protein-bound) uremic toxins. | — |
Secondary
| Measure | Time frame |
|---|---|
| Microcirculation measured by capillaroscopy | — |
Countries
Netherlands
Outcome results
None listed